ATE405284T1 - Von virus abstammende antimikrobielle peptide - Google Patents
Von virus abstammende antimikrobielle peptideInfo
- Publication number
- ATE405284T1 ATE405284T1 AT02724964T AT02724964T ATE405284T1 AT E405284 T1 ATE405284 T1 AT E405284T1 AT 02724964 T AT02724964 T AT 02724964T AT 02724964 T AT02724964 T AT 02724964T AT E405284 T1 ATE405284 T1 AT E405284T1
- Authority
- AT
- Austria
- Prior art keywords
- peptides
- antimicrobial
- llp1
- present
- directed
- Prior art date
Links
- 102000044503 Antimicrobial Peptides Human genes 0.000 title abstract 3
- 108700042778 Antimicrobial Peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 7
- 230000000845 anti-microbial effect Effects 0.000 abstract 3
- 230000002101 lytic effect Effects 0.000 abstract 2
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000713666 Lentivirus Species 0.000 abstract 1
- 101710176384 Peptide 1 Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000324 minimal toxicity Toxicity 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Agronomy & Crop Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/785,058 US20030036627A1 (en) | 2001-02-16 | 2001-02-16 | Virus derived antimicrobial peptides |
| US09/785,059 US6835713B2 (en) | 2001-02-16 | 2001-02-16 | Virus derived antimicrobial peptides |
| PCT/US2002/004432 WO2002066608A2 (en) | 2001-02-16 | 2002-02-13 | Virus derived antimicrobial peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE405284T1 true ATE405284T1 (de) | 2008-09-15 |
Family
ID=27359123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02724964T ATE405284T1 (de) | 2001-02-16 | 2002-02-19 | Von virus abstammende antimikrobielle peptide |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1368050B1 (de) |
| JP (1) | JP4441180B2 (de) |
| AT (1) | ATE405284T1 (de) |
| AU (1) | AU2002255562A1 (de) |
| CA (1) | CA2438787C (de) |
| DE (1) | DE60228420D1 (de) |
| DK (1) | DK1368050T3 (de) |
| ES (1) | ES2312565T3 (de) |
| PT (1) | PT1368050E (de) |
| WO (1) | WO2002079397A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8172395B2 (en) * | 2002-12-03 | 2012-05-08 | Novartis Ag | Medical devices having antimicrobial coatings thereon |
| US7452856B2 (en) * | 2004-07-06 | 2008-11-18 | Seikagaku Corporation | Antibacterial peptide |
| CN110582507A (zh) * | 2017-03-03 | 2019-12-17 | 肽逻辑公司 | 工程化抗微生物两亲性肽及使用方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5714577A (en) * | 1996-01-26 | 1998-02-03 | University Of Pittsburgh | Antimicrobial peptides |
-
2002
- 2002-02-19 AT AT02724964T patent/ATE405284T1/de not_active IP Right Cessation
- 2002-02-19 PT PT02724964T patent/PT1368050E/pt unknown
- 2002-02-19 ES ES02724964T patent/ES2312565T3/es not_active Expired - Lifetime
- 2002-02-19 JP JP2002578400A patent/JP4441180B2/ja not_active Expired - Lifetime
- 2002-02-19 EP EP02724964A patent/EP1368050B1/de not_active Expired - Lifetime
- 2002-02-19 DK DK02724964T patent/DK1368050T3/da active
- 2002-02-19 AU AU2002255562A patent/AU2002255562A1/en not_active Abandoned
- 2002-02-19 CA CA2438787A patent/CA2438787C/en not_active Expired - Lifetime
- 2002-02-19 WO PCT/US2002/004812 patent/WO2002079397A2/en not_active Ceased
- 2002-02-19 DE DE60228420T patent/DE60228420D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002255562A1 (en) | 2002-10-15 |
| CA2438787A1 (en) | 2002-10-10 |
| PT1368050E (pt) | 2008-12-03 |
| ES2312565T3 (es) | 2009-03-01 |
| WO2002079397A2 (en) | 2002-10-10 |
| CA2438787C (en) | 2011-06-07 |
| DE60228420D1 (de) | 2008-10-02 |
| EP1368050A4 (de) | 2005-08-03 |
| EP1368050B1 (de) | 2008-08-20 |
| JP4441180B2 (ja) | 2010-03-31 |
| WO2002079397A3 (en) | 2003-04-24 |
| JP2005505498A (ja) | 2005-02-24 |
| EP1368050A2 (de) | 2003-12-10 |
| DK1368050T3 (da) | 2008-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE539744T1 (de) | Hemmer von serin-protease, insbesondere von hepatitis-c-virus-ns3-ns4a-protease, mit einem kondensierten ringsystem | |
| GEP20104960B (en) | USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN | |
| DE60329201D1 (de) | Substituierte wt1-peptide | |
| BR0113666A (pt) | Inibidores da protease peptidomimética | |
| IL159087A0 (en) | Bridged bicyclic compounds and pharmaceutical compositions containing the same | |
| EP2311851A3 (de) | Inhibitoren der Serinproteasen, insbesondere der HCV-NS3-NS4A-Protease | |
| BR0208183A (pt) | Peptìdeo modificado por wt1 | |
| ATE231549T1 (de) | Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendung | |
| HUP0002224A1 (hu) | Virusellenes hatású benzimidazol-származékok | |
| MY148123A (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| DE60024100D1 (de) | Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen | |
| WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
| WO2005007078A3 (en) | Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars) | |
| WO2009012143A3 (en) | Virus derived antimicrobial peptides | |
| DE60136381D1 (de) | Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität | |
| WO2002072621A3 (en) | Cyclohexapeptide having antimicrobial activity | |
| DE60228420D1 (de) | Von virus abstammende antimikrobielle peptide | |
| KR20040078639A (ko) | 카세인 유도 펩타이드 및 이들의 치료 용도 | |
| IS5956A (is) | Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla | |
| RU2002135669A (ru) | Олигопептиды | |
| DE60036199D1 (de) | Proteaseresistente flint-analoge | |
| ATE375800T1 (de) | Anti-hiv und anti-tumor lysozympeptide sowie fragmente | |
| ATE411812T1 (de) | Peptide zur behandlung von infektionen mit dem herpes-virus | |
| HUP0100937A2 (hu) | Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen | |
| PT1451184E (pt) | Compostos diméricos e sua utilização como agentes antivirais |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |